Physician profile
Heidi Cooper
NPI 1558912790
$618.08
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $277 · 2023: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $164.03 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Eisai INC. | $145.33 | 2021 | |
| Sanofi Pasteur INC. | $50.80 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.59 | 2022-2023 | Jardiance |
| Lilly USA, LLC | $43.50 | 2022 | |
| Pfizer INC. | $30.29 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.70 | 2022 | |
| Exact Sciences Corporation | $22.68 | 2023 | Cologuard Collection Kit |
| Corium, LLC | $19.97 | 2022 | |
| Glaxosmithkline, LLC. | $18.87 | 2021 | |
| Medtronic, INC. | $17.96 | 2023 | Intellis Adaptivestim |
| Idorsia Pharmaceuticals US INC | $15.72 | 2023 | Quviviq |
| Ironshore Pharmaceuticals INC. | $13.93 | 2023 | Jornay Pm |
| Organon LLC | $4.71 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.